
Data transfer technology from IgniteData finds 100% of data from vital signs and lab data were successful.

Data transfer technology from IgniteData finds 100% of data from vital signs and lab data were successful.

Eko CORE 500™ digital stethoscope will be incorporated into Z1608 solution under development for heart failure patients built on Welldoc's digital therapeutic platform.

In support of the recent ARPA-H NITRO OA Cure Moonshot, the online resources identifies major OA treatment trials and allows patients to sign up.

Enhancements to the new edition support pharma and CROs to increase diversity in clinical trials, as well as align recruitment with disease incidence

Acquisition adds more than 120 team members in India with expertise in biometrics and medical writing.

The agency proposes significant revisions to oversight programs for drugs and medical products.

The latest people and business news from the past month, all in one place.

Signant adds DSG’s solution suite to its own capabilities to grow CRO and sponsor services.

Organizations aim to integrate EMR into EDC with new workflow.

In this Q&A, Jimmy Bechtel, MBA, VP of site engagement, Society for Clinical Research Sites discusses evolving challenges in the site landscape, what SCRS is doing to alleviate burden, as well as the organization’s upcoming event, the Global Site Solutions Summit in October 2023.

In this Q&A, Craig Serra, head of commercial solutions and partnerships within the clinical research business unit at Flatiron Health (affiliate of the Roche Group), shares his perspective on clinical research, the role of data, and Flatiron Health’s efforts to that end.

The Accelerating Clinical Trials in the EU initiative formally kicks off, with many stakeholders weighing in on what should be the top priorities and goals.

De Carvalho will front AXON's clinical studies practice globally.

The addition of NEXT Oncology investigators expands Proxima CRO’s Phase I clinical trials network.

A Greenphire study of 600 clinical trial professionals from various stakeholders weigh in on emerging patient engagement trends

Patients will now have more options for how they receive their expense or stipend payments related to clinical trial participation.

Analysis of 13,490 clinical trials finds three of the top five most-studied diseases fall within oncology.

In an interview with Applied Clinical Trials' sister publication, Pharmaceutical Executive, Elizabeth (Beth) Garner, chief scientific officer for Ferring Pharmaceuticals, discusses what it was like transitioning from working as a gynecologic oncologist and seeing patients to working in pharma, specifically clinical trials.

Expansion aims to continue to create programs that address health and education inequities.

WCG publishes report providing assessment of motivators across all clinical research stakeholders, including patients, sites and sponsors.

GxP Inventory available in two options for varying sponsor and CRO requirements.

Privia Care Center locations that do not currently conduct clinical trials will receive embedded research from Velocity.

The confirmatory study—which tracked 18 months of data—helped clear the way for new Alzheimer’s drug.

Union adds to company’s goal of reaching net zero emissions by 2045.

Real-world evidence solutions provider will join Thermo’s Laboratory Products and Biopharma Services segment.

Devana's workflow and analytics solutions will be integrated into RealTime's Site Operations Management System.

Jeff Liter, CEO of Luminary Therapeutics discusses the company's unique approach in the fast-evolving landscape of cancer treatment.

IgniteData will provide data transfer integration between the EHR at MSK and the electronic systems of two major clinical trial sponsors.

Eko Health developed the device, which has received 501(k) clearance from the FDA.

In an interview at the DIA Global Annual Meeting with Nicholas Saraceno, Venkatraman Balasubramanian, SVP and global head, industry solutions, healthcare and life sciences, Orion Innovation, discusses feedback from the audience during his session, “The Case for Generating Synthetic Data as Real-World Data: Regulatory and Planning Perspectives.”